Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coronary bifurcation stenting. Current techniques, outcome and possible future developments.

N Melikian1, F Airoldi, C Di Mario

  • 1Department of Cardiology, Guy's King's and St Thomas' School of Medicine King's College Hospital, Denmark Hill, London, UK.

Minerva Cardioangiologica
|October 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-procedural fever after transcatheter aortic valve implantation: a retrospective single-centre study.

The Journal of hospital infection·2023
Same author

Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy.

Journal of thrombosis and thrombolysis·2023
Same author

Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis.

Frontiers in immunology·2023
Same author

Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype.

Journal of internal medicine·2021
Same author

Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2020
Same author

Interleukin-6 and IgA-rheumatoid factor are crucial for baseline erosiveness, and anti-citrullinated peptide antibodies for radiographic progression in early rheumatoid arthritis treated according to a treat-to-target strategy.

Scandinavian journal of rheumatology·2018

Treating coronary bifurcation lesions with drug-eluting stents (DES) remains challenging. New dedicated DES and stenting techniques are needed to improve outcomes and reduce restenosis rates in side branches.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Research
  • Medical Device Technology

Background:

  • Percutaneous coronary intervention for bifurcation lesions presents challenges, with high restenosis rates.
  • Conventional T-stenting shows limitations in side-branch coverage, leading to persistent restenosis.
  • Drug-eluting stents (DES) have improved main vessel outcomes but not fully addressed side-branch issues.

Purpose of the Study:

  • To evaluate the efficacy of current percutaneous coronary intervention techniques for bifurcation lesions.
  • To identify limitations in achieving optimal side-branch coverage and reducing restenosis.
  • To explore the potential of advanced stenting techniques and dedicated DES for improved outcomes.

Main Methods:

  • Review of percutaneous coronary intervention techniques for coronary bifurcation lesions.

Related Experiment Videos

  • Analysis of restenosis rates associated with different stenting strategies (T-stenting, kissing stents, Culotte, V-stenting, Crush).
  • Assessment of drug-eluting stent (DES) performance in main and side branches.

    • Main Results:

    • Restenosis rates exceed 30% for bifurcation lesions, with no benefit from routine kissing stents.
    • Conventional T-stenting results in double-digit restenosis for side branches due to inadequate ostial coverage.
    • Advanced techniques (Culotte, V-stenting, Crush) offer potential for better lesion coverage.

    Conclusions:

    • Percutaneous treatment of coronary bifurcation lesions requires further optimization.
    • Dedicated drug-eluting stents (DES) may be necessary for consistent procedural and long-term success.
    • Improved ostial coverage and dedicated devices are crucial for reducing side-branch restenosis.